De J. Zenteno-Hernandez
Mexico City, DIF, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Altered levels of IFN-γ, IL-4, and IL-5 depend on the TLR4 rs4986790 genotype in COPD smokers but not those exposed to biomass-burning smoke.
Journal: Frontiers in immunology
Published: April 02, 2024
Association of PADI2 and PADI4 polymorphisms in COVID-19 host severity and non-survival.
Journal: Heliyon
Published: November 15, 2023
sRAGE levels are decreased in plasma and sputum of COPD secondary to biomass-burning smoke and tobacco smoking: Differences according to the rs3134940 AGER variant.
Journal: Heliyon
Published: November 06, 2023
Variant rs4986790 of toll-like receptor 4 affects the signaling and induces cell dysfunction in patients with severe COVID-19.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: September 18, 2023
High Expression Levels of miR-21-5p in Younger Hospitalized COVID-19 Patients Are Associated with Mortality and Critical Disease.
Journal: International journal of molecular sciences
Published: May 10, 2023
The ACE rs1799752 Variant Is Associated with COVID-19 Severity but Is Independent of Serum ACE Activity in Hospitalized and Recovered Patients.
Journal: International journal of molecular sciences
Published: March 22, 2023
SNPs Sets in Codifying Genes for Xenobiotics-Processing Enzymes Are Associated with COPD Secondary to Biomass-Burning Smoke.
Journal: Current issues in molecular biology
Published: December 09, 2022
Clinical and microbiological characteristics and inflammatory profile during an exacerbation of COPD due to biomass exposure. A comparison with COPD due to tobacco exposure.
Journal: Respiratory medicine
Published: August 12, 2022
Outcome predictors in COVID-19: An analysis of emergent systemic inflammation indices in Mexican population.
Journal: Frontiers in medicine
Published: July 21, 2022
COVID-19 Survivor Patients Carrying the Rs35705950 Risk Allele in MUC5B Have Higher Plasma Levels of Mucin 5B.
Journal: Current issues in molecular biology
Published: June 21, 2022
IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19.
Journal: Frontiers in immunology
Published: May 20, 2022
SERPINE1 rs6092 Variant Is Related to Plasma Coagulation Proteins in Patients with Severe COVID-19 from a Tertiary Care Hospital.
Journal: Biology
Published: February 24, 2022
Last Updated: 09/26/2026